BubbleFect at SLAS Europe 2026 — Innovation AveNew and SLAS Ignite Awards Shortlist

This May, PartitionBio is heading to SLAS Europe 2026 in Vienna. One of the leading gatherings for innovation in life sciences, laboratory automation, and drug discovery. Hosted at the VIECON Vienna Congress & Convention Center, the event brings together scientists, startups, pharma leaders, and technology providers to explore the future of research and translational science.


Why SLAS Europe 2026 Is the Right Stage for BubbleFect

SLAS is more than a conference. It’s a convergence point for emerging technologies and real-world applications in biology. This year’s programme highlights themes like:

  • Automation in life sciences and agri-tech;

  • DNA-encoded libraries and lead discovery;

  • Sustainability in research;

  • Sample management and workflow optimisation.

These themes align closely with what we’re building at PartitionBio. Our BubbleFect platform sits right at the intersection of innovation in cell transfection, delivery systems, and scalable biology workflows. Areas that are central to the conversations happening across the event.


Vienna Congress Centre exterior, venue for SLAS Europe 2026 conference and exhibition
SLAS Innovation AveNEW exhibition floor with multiple biotech company stands and attendees

BubbleFect Selected for SLAS Innovation AveNew Startup Showcase

We’re proud to share that PartitionBio has been accepted into Innovation AveNew, SLAS’s dedicated startup showcase.

Being part of this programme means:

  • A curated exhibition space designed for emerging companies;

  • Direct exposure to investors, collaborators, and industry leaders;

  • Built-in tools like lead capture and visibility through SLAS branding;

  • A platform to demonstrate our technology in a high-impact setting.

For us, this isn’t just a booth. It’s a signal that what we’re building is relevant, needed, and worth watching.


SLAS Innovation AveNEW programme logo
PartitionBio founder presenting the market problem slide at a SLAS conference, showing the evolution of cell delivery methods from the 1950s to the 2020s

BubbleFect for Drug Discovery, Transfection and Scalable Biology Workflows

At SLAS, the audience includes scientists and decision-makers from organisations like AstraZeneca and Boehringer Ingelheim, alongside leading academic researchers.

This is exactly the ecosystem where BubbleFect thrives:

  • Researchers looking for efficient, scalable transfection solutions;

  • Drug discovery teams needing reliable delivery systems;

  • Labs exploring automation-ready biological workflows.

We’re excited to show how BubbleFect can integrate into these pipelines and unlock new experimental possibilities.



PartitionBio Shortlisted for the SLAS Ignite Awards 2026

We're thrilled to share that PartitionBio has been shortlisted for the SLAS Ignite Awards — and Zehra's video application got us here.

Being shortlisted places us among a cohort of high-potential innovators selected from applicants across the global life sciences community. We are incredibly proud to have made it this far.

As finalists, we will:

  • Present live at SLAS in Vienna;

  • Be evaluated by expert judges;

  • Take part in interviews and gain additional exposure.

The Ignite Award winner receives €5,000 and invaluable go-to-market feedback from industry judges — but beyond the prize, this is a powerful platform to amplify what we are building and show the world what BubbleFect can do.

Watch this space. 🚀


The BubbleFect Stand at SLAS Europe 2026

If you’ve seen us at ELRIG events, you’ll know we don’t do boring booths.

We’re bringing back our iconic gumball machine, complete with crocheted cells and surprise treats… but this time with a Vienna-ready upgrade:

  • Fully transportable (no bulky metal gumball machine);

  • Packed with hundreds of capsules;

  • Designed to spark conversations, not just hand out swag.

Because great science deserves great engagement!



Meet the PartitionBio Team at SLAS Europe 2026

Representing PartitionBio in Vienna:

  • Craig Smith, Senior Marketing Manger – focused on investors, media agencies, general interest and partnerships.

  • Dr Zehra Nizami, Head of Business Development and Principal Scientist – focused on liquid-lquid phase seperation / biomolecular condensates, business development, partnerships and end-user optimisations and workflows.

We’re both there to:

  • Meet researchers, biotech teams, and pharma partners;

  • Explore collaborations and pilot opportunities;

  • Connect with media, podcast hosts, and content platforms.



Collaborations and Partnerships at SLAS Europe 2026

SLAS is about more than exhibiting, it’s about building momentum.

We’re particularly keen to connect with:

  • Media and science communication platforms;

  • Other exhibitors and startups;

  • Delegates interested in next-gen transfection technologies.

We’re also continuing to grow our content ecosystem, and SLAS is the perfect place to find voices shaping the future of biology.


Post-SLAS: BubbleFect Early Access and Exclusive Offers

Our engagement doesn’t stop when the exhibition closes.

We’ve secured a post-event delegate email campaign, where we’ll be sharing:

  • Exclusive materials and deeper insights into BubbleFect;

  • Early data and use cases;

  • Special offers and discounts for early adopters.

If you don’t catch us at SLAS, we’ll still make sure you don’t miss what’s next.


Find PartitionBio at SLAS Europe 2026 in Vienna

SLAS Europe 2026 is shaping up to be a defining moment for PartitionBio. From Innovation AveNew to the Ignite Awards, from BubbleFect demos to gumball machine conversations… we’re showing up ready to connect, collaborate, and push boundaries.

If you’re attending, come find us.


Previous
Previous

BubbleFect vs Lipid-Based Transfection Reagents — Better Efficiency, Higher Cell Viability, Simpler Protocol

Next
Next

BubbleFect at ELRIG Cell & Gene Therapy 2026 — Non-Viral Delivery for Cell and Gene Therapy Research